Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Nutrient stimulation of enteroendocrine L cells induces the release of the incretin and satiating peptide glucagon-like peptide 1 (GLP-1). The vagus nerve innervates visceral organs and may contribute to the mediation of gut-derived GLP-1’s effects on food intake, energy homeostasis, and glycemic control. To test the hypothesis that vagal afferent neuron (VAN) GLP-1 receptors (GLP-1Rs) are necessary for these effects of endogenous GLP-1, we established a novel bilateral nodose ganglia injection technique to deliver a lentiviral vector and to knock down VAN GLP-1Rs in male Sprague Dawley rats. We found that a full expression of VAN GLP-1Rs is not necessary for the maintenance of long-term energy balance in normal eating conditions. VAN GLP-1R knockdown (kd) did, however, increase meal size and accelerated gastric emptying. Moreover, postmeal glycemia was elevated and insulin release was blunted in GLP-1R kd rats, suggesting that VAN GLP-1Rs are physiological contributors to the neuroincretin effect after a meal. Collectively, our results highlight a crucial role for the VANs in mediating the effects of endogenous GLP-1 on food intake and glycemia and may promote the further development of GLP-1–based therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1RAs can exert their local effects by activating vagal dendritic terminals that innervate the gut.418–420”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [418]
In the citing paper
“Peripheral GLP-1/GLP-1RAs may also interact with the CNS indirectly by GLP-1R expressed on vagal afferent fibers, signaling via nodose ganglia (57) to the nucleus tractus solitarii within the brainstem.”
From The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications (2026) · cites this paper as [57]
In the citing paper
“Importantly, knockdown of GLP-1R in VANs increased meal size (39), and abolished the satiating effects of secretagogue-induced GLP-1 release (34).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [39]
In the citing paper
“Given the role of GLP-1R-expressing VANs in physiological satiation (23, 39)”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [39]
Citations
Cites
Functional and chemical anatomy of the afferent vagal system
Berthoud, H.-R., & Neuhuber, W. L. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00215-0 · Cited by 1,280 · cited 13×
“We measured HPV blood glucose in the fasted and fed conditions in control and GLP-1R kd rats.”
BackgroundInfluentialSensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
Erickson, J. C., Clegg, K. E., & Palmiter, R. D. (1996) · Nature · doi:10.1038/381415a0 · Cited by 1,008 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodVilsboll, T., Christensen, M., Junker, A. E., Knop, F. K., & Gluud, L. L. (2012) · BMJ · doi:10.1136/bmj.d7771 · Cited by 970
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 2×
“Recent studies, however, have shown that GLP-1R agonists, such as liraglutide, exert their body weight and glucose-lowering effects independent of vagal afferents (45) and do not require VAN GLP-1Rs (17).”
BackgroundAbbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Ghatei, M. A., & Bloom, S. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.011 · Cited by 599 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodVagal Sensory Neuron Subtypes that Differentially Control Breathing
Chang, R. B., Strochlic, D. E., Williams, E. K., Umans, B. D., & Liberles, S. D. (2015) · Cell · doi:10.1016/j.cell.2015.03.022 · Cited by 439 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodGlucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5027-5035.2002 · Cited by 430 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodNeuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
Sisley, S., Gutierrez-Aguilar, R., Scott, M., D’Alessio, D. A., Sandoval, D. A., & Seeley, R. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72434 · Cited by 397 · cited 3×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodResultKanoski, S. E., Fortin, S. M., Arnold, M., Grill, H. J., & Hayes, M. R. (2011) · Endocrinology · doi:10.1210/en.2011-0174 · Cited by 347 · cited 5×
“Together, this strengthens the classical view that VAN GLP-1Rs mainly mediate shortterm satiation and may be one of several redundant eating control mechanisms comprising the gut-brain axis (7,9,16,33).”
BackgroundMethodSelf-citation
Research works printed but not linked: 1
- Arnold, 2012, Intraperitoneal (IP) glucagon-like peptide-1 (GLP-1) injections and meals in rats increase intestinal lymphatic GLP-1 similarly, Appetite, 59, e3
Cited by
Items 201–265 of 265
Galsgaard, K. D., Modvig, I. M., & Holst, J. J. (2025) · Biochemical Society Transactions · doi:10.1042/bst20241062 · Cited by 4
Merchant, W., Tinajero, A., KHAN, A. R., Chu, Y., Saleh, S., Tasabehji, D., Morgan, D. A., Williams, K. W., Rahmouni, K., Mokadem, M., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00452.2025 · Cited by 4
Zheng, Z., Pettus, J., Warner, A., Jones, B., Pugsley, M., Stege, J. T., Hirakawa, B. P., Jaiman, M., Tolentino, J. C., Lee, T., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102340 · Cited by 4
“Consistent with these functional findings, enteroendocrine cells form direct, synapse-like connections with vagal sensory neurons, enabling rapid neural transmission of gut signals to the brainstem on a millisecond time-scale, prior to endocrine dissemination via the systemic circulation [21,22].”
The critical role of gut–brain signalling in eating behaviour and obesity
de Lartigue, G., Brierley, D. I., & Choi, H. J. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01203-x · Cited by 6
“29)), or deleting neuropeptides that are released from VANs into the hind-brain in response to a meal 30 , all lead to overeating and weight gain.”
Bashaw, A. G., Roman-Ortiz, C., Gao, S. X., Schier, L. A., Borner, T., & Kanoski, S. E. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.006 · Cited by 5
Zhou, M., Du, M., Tang, R., Liu, H., Gao, Z., Wang, Y., You, H., Hao, J.-W., Ji, Z., Wang, D., et al. (2023) · Neuroendocrinology · doi:10.1159/000529438 · Cited by 5
GLP-1 Increases Circulating Leptin Levels in Truncal Vagotomized Rats
Morais, T., Pereira, S. S., Andrade, S., Neves, D., Guimarães, M., Nora, M. C., Carreira, M. C., Casanueva, F. F., & Monteiro, M. P. (2023) · Biomedicines · doi:10.3390/biomedicines11051322 · Cited by 4
“GLP-1R activity in vagal afferent neurons were recognized to be crucial to mediate the effects of endogenous GLP-1 on food intake [38], but not necessarily for GLP-1 analogues that seem to act directly on the hypothalamic neurons [39].”
BackgroundA sympathetic brake on gut GLP-1 release
López-Gambero, A. J., Jouque, V., & Cota, D. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.015 · Cited by 4
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Lian, K., Zhang, K., Kan, C., Hou, N., Han, F., Sun, X., Qiu, H., & Guo, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122801 · Cited by 6
Holst, J. J. (2024) · The Journal of Physiology · doi:10.1113/jp287461 · Cited by 5
Li, S., Chen, W., Ma, S., Zhou, X., Li, J., & Li, B. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142089 · Cited by 4
Ohbayashi, K., Tanida, M., Abe, C., Ishihara, H., Omi, W., Kubota, N., Drucker, D. J., Yada, T., & Iwasaki, Y. (2026) · Diabetes · doi:10.2337/db25-1134 · Cited by 5
Lauer, L. T., Hayes, A., Suarez, A. N., Bashaw, A. G., Klug, M. E., Kao, A. E., Cheng, R., Rea, J. J., Subramanian, K. S., Nourbash, A. C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73896-2 · Cited by 3
Yang, G., Burgess, S., & Schooling, C. M. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04244-7 · Cited by 3
“GLP-1R agonists act on the hindbrain, the hypothalamus, and vagal afferents to suppress food intake and reduce body weight [4 – 6].”
InfluentialGut Hormones and Inflammatory Bowel Disease
Weng, J., & Lo, C. C. (2025) · Biomolecules · doi:10.3390/biom15071013 · Cited by 7
Peart, L. A., Draper, M., & Tarasov, A. I. (2024) · Peptides · doi:10.1016/j.peptides.2024.171243 · Cited by 5
Shao, Y.-W., Tian, J., Yang, Y., Hu, Y., Zhu, Y., & Shu, Q. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.931161 · Cited by 4
“Therefore, it is generally believed that GLP-1R is a chemosensory neuron of the vagal afferents nerve, which helps the vagal afferents nerve receive nutrient detection information in a paracrine manner by binding to GLP-1 released locally by enteroendocrine cells (Krieger et al., 2016; Grill, 2020).”
BackgroundTamer, S. A., & Yeğen, B. Ç. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137122 · Cited by 2
Akıncı, B., Ajluni, N., Meral, R., Neidert, A., de Freitas, M. F., Gilio, D., Conjeevaram, H. S., & Oral, E. A. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf067 · Cited by 2
“Additionally, GLP-1 and leptin share overlapping pathways in the hypothalamus, where they synergistically reduce food intake [20].”
AgRP mediated calcium Inhibition of feeding via the vagal afferent nerve-brain pathway
Su, A., Pan, L., Zhou, Q., Zhu, Q., Li, R., Liu, M., Wu, R., Wang, L., Wang, S., Jiang, Q., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01409-7 · Cited by 2
“Multiple studies have shown that receptors in the vagal nerve endings can sense appetite signal in the gastrointestinal tract and transmit them to the central nervous system, thereby affecting appetite [27, 28].”
Iba, K., Kitano, R., & Iwasaki, Y. (2025) · Physiological Reports · doi:10.14814/phy2.70636 · Cited by 4
Incretin-Based Therapies: A Novel Pathway in Addiction Treatment
Rosiejka, D., Joanna, M., Marcickiewicz, J., Bogdańska, A., Błażejewska, W., & Szulińska, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041613 · Cited by 2
“This vagal activation stimulates central pathways in the nucleus tractus solitarius that reduce efferent vagal tone to the stomach [44,45].”
Serendipity and spontaneity – Critical components in 40 years of academia
Langhans, W. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.02.011 · Cited by 3
Self-citationNovel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article.
Kardan, R., Hemmati, J., Nazari, M., Ahmadi, A., Asghari, B., Azizi, M., Khaledi, M., & Arabestani, M. R. (2024) · PubMed Central · doi:10.22088/cjim.15.2.215 · Cited by 5
“This hormone stimulates the digestion of fat and protein through the release of digestive enzymes and bile from the pancreas and gallbladder (80).”
BackgroundThe Gastrointestinal Tract and Control of Food Intake
de Lartigue, G., & Raybould, H. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00062-1 · Cited by 2
Watkins, J. D., Smith, H., Hengist, A., Nielsen, S. B., Mikkelsen, U. R., Saunders, J., Koumanov, F., Betts, J. A., & Gonzalez, J. T. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524000321 · Cited by 6
“Whilst GLP-1 stimulates glucose-dependent insulin secretion (3,4) , both GLP-1 and PYY delay gastric emptying (5,6) and reduce food intake (7,8) .”
BackgroundPACAP Signalling Network in the Nucleus Accumbens Core Regulates Reinstatement Behaviour in Rat
Bose, S., Simandl, G. J., Hess, E. M., Kong, L., Raddatz, N. J., Maunze, B., Choi, S., & Baker, D. L. (2025) · Addiction Biology · doi:10.1111/adb.70090 · Cited by 2
Masuda, Y., Kawase, M., Kitano, R., Ohbayashi, K., Yabe‐Wada, T., Inoue, H., Tanida, M., & Iwasaki, Y. (2026) · The Journal of Physiology · doi:10.1113/jp290717 · Cited by 2
“Although the roles of vagal sensory nerves in feeding and glucose metabolism have been extensively studied (Krieger et al., 2016; Li et al., 2022; McDougle et al., 2024; Tan et al., 2020), their contribution to thermoregulation including postprandial thermogenesis remains poorly understood.”
Kassardjian, A., & Shafizadeh, N. (2026) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqag108 · Cited by 1
The Gut Microbiota and NDG: What Is the Interplay
Haiba, S., Idriss, S., & Awad, M. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_30-1 · Cited by 1
Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_26 · Cited by 2
The Role of Vagal Afferent Nerves in Feeding Regulation
Ohbayashi, K., Nohmi, T., & Iwasaki, Y. (2023) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.76.95 · Cited by 2
Silencing gut CCK cells alters gut reaction to sugar
Yue, J. T. Y., Duca, F. A., & Lam, T. K. T. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00998-z · Cited by 1
A neural entero-pancreatic pathway that regulates insulin secretion and glucose tolerancePreprint
Sokolov, M., Tamayo, A., Levi, N., Seeley, R. J., & Caicedo, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.14.670343 · Cited by 1
Gastrointestinal Hormones and the Control of Food Intake and Energy Metabolism
PAGE, L. C., Miller, M. D., D’Alessio, D. D., & Tong, J. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_3 · Cited by 1
Endocrine Control of Food Intake
Langhans, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95809-4
Self-citationFarr, S. (2017) · TSpace (University of Toronto)
Zhang, Q., Zhang, X., & Niu, C.-Y. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i11.393
Taher, J. (2017) · TSpace (University of Toronto) · Cited by 1
The vagal nerves—Important connectors of the gut and brain for energy balance
Raza, G. S., & Herzig, K. (2020) · Acta Physiologica · doi:10.1111/apha.13605
食後ホルモンインスリン・GLP-1の求心性迷走神経を介した摂食・糖代謝調節
岩﨑, 有., & 俊彦, 矢. (2021) · 自律神経 · doi:10.32272/ans.58.1_105
Descifrando las funciones de la microbiota intestinal en la obesidad.
López‐Almela, I. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/174897
Therapeutic potential of zein-based nanoparticles
Reboredo, C. (2022) · doi:10.15581/10171/62894
Regional Intestinal Drug Absorption
Gonzalez-Alvarez, M. I., & Dahan, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3657-6
Vague afférent, GLP-1, prise alimentaire et homéostasie du glucose
A., F. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30016-5
Rao, N., Jauhari, R., Sati, V., & Godiyal, P. (2022) · Journal of Applied Pharmaceutical Sciences and Research · doi:10.31069/japsr.v5i2.02 · Cited by 1
“44 Knocking down GLP-1Rs in VANs by injecting a lentiviral vector in the NG increases meal size, accelerates gastric emptying, increases postmeal glycemia, and blunts insulin release.”
BackgroundThe Gut Microbiota and NDG: What Is the Interplay
Haiba, S., Idriss, S., & Awad, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_30
Slow mechanisms for inhibiting eating: Appetite, satiety, and their control
Carr, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29218-7.00020-1
Jiang, W.-L., Hu, X.-Y., Zheng, H.-X., Nan, M.-H., Li-zhe, L., Tian-xu, W., Li, J.-L., & Bai, C.-C. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.119126
GLP-1 RECEPTOR AGONISTS AND ALCOHOL USE DISORDER: PROMISE FOR A NEW TREATMENT APPROACH
Fidelus, J., Jurkowska, K., Dutkiewicz, D., Madrzak, J., Endler, O., Dybicz, M., Ciastoń, M., Filuk, M., Czerniewska, J., & Handzel, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5617
Dietary bioactive compounds modulating satiety and appetite: mechanisms of action
Casado‐Hidalgo, G., Pueyo-Arias, M., Gil‐Cardoso, K., Les, F., Mariné-Casadó, R., Pinent, M., Ardèvol, A., Lorente‐Cebrián, S., Capel, F., Escoté, X., et al. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01185-z
“Interestingly, the sensitivity of gastric vagal afferent tension receptors, which play a key role in sensing gastric distension, can be influ - enced by factors such as the composition of the diet (e.g., a high-fat diet) and physiological states like pregnancy [21, 22].”
Navigating gut-liver metabolic homeostasis: the role of the autonomic nervous system
Sun, R., He, J.-L., Cheng, Y., Yu, S.-R., Zhang, M.-N., Yang, M., Chen, K., Wu, M.-Y., & Chai, J. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2026.37 · Cited by 1
Langhans, W. (2026) · CardioVasc · doi:10.1007/s15027-026-4010-7
“Erstere und die davon abgeleiteten Dual-und Triple-Agonisten wirken direkt im Gehirn, während das endogene periphere GLP-1 primär über die Aktivierung sensori-scher Vagusfasern in der Darmwand Sättigung induziert [13, 18].”
Self-citationRegulators of appetite in mammals—old and new players
Fernandes, J. H., Silva, J. D., Costa, M. D., & Maciel, P. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag020 · Cited by 1
Zhang, S. Z., Tu, J., Hong, W., Liu, J., Xue, C., & Dong, N. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.02412-25
Lipid sensing and brain hormone receptors in food intake and glucose regulation
Garrido, A. N., Lyons, S. A., MOSLEMIAN, D., Beaudry, J. L., & Lam, T. K. T. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01278-1
“Moreover, vagal Glp1r ablation increases gastric emptying in rodents 66,67 , providing an additional mechanism through which endogenous GLP1 might regulate food intake.”
InfluentialNodoMap: A single-cell and spatial transcriptomic atlas of the mouse nodose ganglion
Cheng, S., Dowsett, G. K. C., Rainbow, K., Norton, M., Roberts, A. G., Phuah, P., Bewick, G. A., Lam, B., Yeo, G. S. H., & Murphy, K. G. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100072 · Cited by 1
Ding, Z., Li, Q., Li, Z., & Li, X. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61200-9
For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?
Giang, C., Meng, J., Mohammad, M. A., Liu, Z., Wu, X., & Zhu, Y. (2026) · Biology · doi:10.3390/biology15161395 · Cited by 1
“In rodents, peripheral GLP-1 activates vagal afferents that project to the nucleus tractus solitarius (NTS), where second-order neurons integrate gastrointestinal signals to suppress meal size [71].”
GLP-1 receptor biology and the therapeutic role of incretin-based agonists in metabolic diseases
Koceva, E., & Moll, G. N. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179406
Kumbhare, S. V., Pedroso, I., Sinha, R., & Almonacid, D. E. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2026.2016564
Metadata
- Authors
- Krieger, J.-P., Arnold, M., Pettersen, K. G., Lossel, P., Langhans, W., & Lee, S. J.
- Affiliations
- ETH Zurich (CH)
- Corresponding author
- Krieger, Jean-Philippe
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-10-15
- Volume
- 65
- Issue
- 1
- Pages
- 34-43
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2180065345
- Cited by
- 269
- References
- 43
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 36 · 2023: 15 · 2022: 19 · 2021: 33 · 2020: 26 · 2019: 21 · 2018: 24 · 2017: 23 · 2016: 17 · 2015: 1
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- ETH Zurich (4712-2)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- GLP-1 receptor, vagal afferent neurons, nodose ganglion, gene knockdown, dietary intake, glycemia, insulin secretion, gastric emptying, meal size, energy homeostasis, enteroendocrine L cells
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Insulin Secretion, Animals, Blood Glucose, Eating, Energy Metabolism, Gastric Emptying, Insulin, Intestines, Male, Neurons, Afferent, Nodose Ganglion, Vagus Nerve, Rats, Sprague-Dawley, Postprandial Period, Rats, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.